Diabetes and risk of bladder cancer among postmenopausal women in the Iowa women's health study

Cancer Causes and Control

Volumn 24, Issue 3, 2013, Pages 603-608

  Prizment, Anna E ^a   Anderson, Kristin E ^a,b   Yuan, Jian Min ^c,d   Folsom, Aaron R ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Bladder cancer; Diabetes; Prospective study

Indexed keywords

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; BODY MASS; CANCER GROWTH; CANCER RISK; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; PATIENT ASSESSMENT; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; UNITED STATES; WAIST HIP RATIO; WOMEN'S HEALTH; COHORT ANALYSIS; DIABETES COMPLICATIONS; IOWA; MIDDLE AGED; PROSPECTIVE STUDY; RISK FACTOR; URINARY BLADDER NEOPLASMS;

AGED; COHORT STUDIES; DIABETES COMPLICATIONS; FEMALE; HUMANS; IOWA; MIDDLE AGED; POSTMENOPAUSE; PROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES; URINARY BLADDER NEOPLASMS; WOMEN'S HEALTH;

EID: 84878827475     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-012-0143-3     Document Type: Article

References (36)

1. American Cancer Society (2012) Cancer facts & figures 2012. American Cancer Society, Atlanta
2. World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity and the prevention of cancer: a global perspective. AICR, Washington DC
3. Freedman N, Silverman D, Hollenbeck A, Schatzkin A, Abnet C (2011) Association between smoking and risk of bladder cancer among men and women. JAMA (Chicago, IL) 306:737-745
4. Silverman DT, Devesa SS, Moore LE, Rothman N (2006) Bladder cancer. In: Schottenfeld D, Fraumeni JFJ (eds) Cancer epidemiology and prevention. Oxford University Press, New York, pp 1101-1128
5. Larsson S, Orsini N, Brismar K, Wolk A (2006) Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia 49:2819-2823
6. Tripathi A, Folsom A, Anderson K (2002) Risk factors for urinary bladder carcinoma in postmenopausal women. The Iowa Women's Health Study. Cancer 95:2316-2323
7. Folsom AR, Kaye SA, Sellers TA et al (1993) Body fat distribution and 5-year risk of death in older women. JAMA 269:483-487
8. Bisgard KM, Folsom AR, Hong CP, Sellers TA (1994) Mortality and cancer rates in nonrespondents to a prospective study of older women: 5-year follow-up. Am J Epidemiol 139:990-1000
9. Fritz A, Percy C, Jack A (2000) International classification of disease for oncology (ICD-O), 3rd edn. WHO, Geneva
10. Anderson KE, Anderson E, Mink PJ et al (2001) Diabetes and endometrial cancer in the Iowa women's health study. Cancer Epidemiol Biomarkers Prev 10:611-616
11. Limburg P, Anderson K, Johnson T et al (2005) Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa women's health study. Cancer Epidemiol Biomarkers Prev 14:133-137
12. Allison PD (2010) Survival analysis using SAS: a practical guide. SAS Institute
13. ACSM'S Health-Related Physical Fitness Assessment Manual (2008) 2nd edn. Lippincott Williams & Wilkins, Philadelphia, p 59
14. Johnson JA, Carstensen B, Witte D, Bowker SL, Lipscombe L, Renehan AG (2012) Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence. Diabetologia 55:1607-1618
15. Colmers I, Bowker S, Majumdar S, Johnson J (2012) Use of thiazolidinediones and the risk of bladder cancer among people with type 2 diabetes: a meta-analysis. Can Assoc Med 184:E675-E683
16. Tseng C (2012) Pioglitazone and bladder cancer: a population-based study of Taiwanese. Diabetes Care 35:278-280
17. Mamtani R, Haynes K, Bilker W et al (2012) Association between longer therapy with thiazolidinediones and risk of bladder cancer: a cohort study. J Natl Cancer Inst 104:1411-1421
18. Onitilo A, Engel J, Glurich I, Stankowski R, Williams G, Doi S (2012) Diabetes and cancer II: role of diabetes medications and influence of shared risk factors. Cancer Causes Control 23:991-1008
19. Evans JMM (2005) Metformin and reduced risk of cancer in diabetic patients. Br Med J 330:1304-1305
20. Atchison E, Gridley G, Carreon JD, Leitzmann M, McGlynn K (2011) Risk of cancer in a large cohort of U.S. veterans with diabetes. Int J Cancer 128:635-643
21. Larsson S, Andersson S, Johansson J, Wolk A (2008) Diabetes mellitus, body size and bladder cancer risk in a prospective study of Swedish men. Eur J Cancer 44:2655-2660
22. Noto H, Osame K, Sasazuki T, Noda M (2010) Substantially increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis of epidemiologic evidence in Japan. J Diabetes Complicat 24:345-353
23. Newton C, Gapstur S, Campbell P, Jacobs E (2012) Type 2 diabetes mellitus, insulin use, and risk of bladder cancer in a large cohort study. Int J Cancer. doi: 10.1002/ijc.27878
24. MacKenzie T, Zens M, Ferrara A, Schned A, Karagas M (2011) Diabetes and risk of bladder cancer: evidence from a case-control study in New England. Cancer 117:1552-1556
25. Tseng CH (2011) Diabetes and risk of bladder cancer: a study using the national health insurance database in Taiwan. Diabetologia 54:2009-2015
26. Woolcott C, Maskarinec G, Haiman C, Henderson B, Kolonel L (2011) Diabetes and urothelial cancer risk: the multiethnic cohort study. Cancer Epidemiol 35:551-554
27. Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R (2009) Diabetes and cancer. Endocr Relat Cancer 16:1103-1123
28. Giovannucci E, Harlan DM, Archer MC et al (2010) Diabetes and cancer: a consensus report. CA Cancer J Clin 60:207-221
29. Dunn SE, Kari FW, French J et al (1997) Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Res 57:4667-4672
30. Zhao H, Grossman HB, Spitz M, Lerner S, Zhang K, Wu X (2003) Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk. J Urol 169:714-717
31. Jiang X, Castelao JE, Groshen S et al (2009) Urinary tract infections and reduced risk of bladder cancer in Los Angeles. Br J Cancer 100:834-839
32. Sinha MK, Ohannesian JP, Heiman ML et al (1996) Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects. J Clin Invest 97:1344-1347
33. Saxena M, Agrawal C, Gautam S, Bid H, Banerjee M (2009) Overt diabetic complications in obese Type 2 diabetes mellitus patients from North India. Arch Appl Sci Res 1:57-66
34. Simpson C, Boyd C, Carlson M, Griswold M, Guralnik J, Fried L (2004) Agreement between self-report of disease diagnoses and medical record validation in disabled older women: factors that modify agreement. J Am Geriatr Soc 52:123-127
35. Kaye SA, Folsom AR, Sprafka JM, Prineas RJ, Wallace RB (1991) Increased incidence of diabetes mellitus in relation to abdominal adiposity in older women. J Clin Epidemiol 44:329-334
36. Centers for Disease Control and Prevention (CDC) (2011) National diabetes fact sheet, 2011. http://www.cdc.gov/diabetes/pubs/pdf/ndfs-2011.pdf. Accessed May 2012